Chappell DL - Search Results

1

Comparative inhibitory activity of etoricoxib, celecoxib, and diclofenac on COX-2 versus COX-1 in healthy subjects.

Schwartz JI, Dallob AL, Larson PJ, Laterza OF, Miller J, Royalty J, Snyder KM, Chappell DL, Hilliard DA, Flynn ME, Cavanaugh PF Jr, Wagner JA. Schwartz JI, et al. Among authors: chappell dl. J Clin Pharmacol. 2008 Jun;48(6):745-54. doi: 10.1177/0091270008317590. Epub 2008 Apr 23. J Clin Pharmacol. 2008. PMID: 18434566 Clinical Trial.

2

Development and validation of a LC/MS/MS method for 6-keto PGF1α, a metabolite of prostacyclin (PGI₂).

Chappell DL, Xiao X, Radziszewski W, Laterza OF. Chappell DL, et al. J Pharm Biomed Anal. 2011 Nov 1;56(3):600-3. doi: 10.1016/j.jpba.2011.06.019. Epub 2011 Jun 29. J Pharm Biomed Anal. 2011. PMID: 21782371

3

Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer's disease from other dementias and healthy controls in the OPTIMA cohort.

Seeburger JL, Holder DJ, Combrinck M, Joachim C, Laterza O, Tanen M, Dallob A, Chappell D, Snyder K, Flynn M, Simon A, Modur V, Potter WZ, Wilcock G, Savage MJ, Smith AD. Seeburger JL, et al. J Alzheimers Dis. 2015;44(2):525-39. doi: 10.3233/JAD-141725. J Alzheimers Dis. 2015. PMID: 25391385

4

Development and validation of an ultra-sensitive method for the measurement of plasma renin activity in human plasma via LC-MS/MS.

Chappell DL, McAvoy T, Weiss B, Weiner R, Laterza OF. Chappell DL, et al. Bioanalysis. 2012 Dec;4(23):2843-50. doi: 10.4155/bio.12.268. Bioanalysis. 2012. PMID: 23216124

5

Quantitation of human peptides and proteins via MS: review of analytically validated assays.

Chappell DL, Lassman ME, McAvoy T, Lin M, Spellman DS, Laterza OF. Chappell DL, et al. Bioanalysis. 2014;6(13):1843-57. doi: 10.4155/bio.14.145. Bioanalysis. 2014. PMID: 25157489 Review.

6

The clinical utility of mass spectrometry based protein assays.

Lassman ME, McAvoy T, Chappell DL, Lee AY, Zhao XX, Laterza OF. Lassman ME, et al. Among authors: chappell dl. Clin Chim Acta. 2016 Aug 1;459:155-161. doi: 10.1016/j.cca.2016.05.027. Epub 2016 Jun 1. Clin Chim Acta. 2016. PMID: 27259466 Review.

7

An evaluation of an aptamer for use as an affinity reagent with MS: PCSK9 as an example protein.

Gupta V, Lassman ME, McAvoy T, Lee AY, Chappell DL, Laterza OF. Gupta V, et al. Among authors: chappell dl. Bioanalysis. 2016 Aug;8(15):1557-1564. doi: 10.4155/bio-2016-0046. Epub 2016 Jul 11. Bioanalysis. 2016. PMID: 27397798

8

Development and validation of an IA-LC/MS method to quantitate active and total B-type natriuretic peptide in human plasma.

Chappell DL, Lee AY, Bernstein HS, Lassman ME, Laterza OF. Chappell DL, et al. Bioanalysis. 2016 Nov;8(22):2341-2349. doi: 10.4155/bio-2016-0195. Epub 2016 Oct 7. Bioanalysis. 2016. PMID: 27712087

9

An ultrasensitive method for the quantitation of active and inactive GLP-1 in human plasma via immunoaffinity LC-MS/MS.

Chappell DL, Lee AY, Castro-Perez J, Zhou H, Roddy TP, Lassman ME, Shankar SS, Yates NA, Wang W, Laterza OF. Chappell DL, et al. Bioanalysis. 2014 Jan;6(1):33-42. doi: 10.4155/bio.13.280. Bioanalysis. 2014. PMID: 24341493

10

Multiplexed Quantification of Proglucagon-Derived Peptides by Immunoaffinity Enrichment and Tandem Mass Spectrometry after a Meal Tolerance Test.

Lee AY, Chappell DL, Bak MJ, Judo M, Liang L, Churakova T, Ayanoglu G, Castro-Perez J, Zhou H, Previs S, Souza SC, Lassman ME, Laterza OF. Lee AY, et al. Among authors: chappell dl. Clin Chem. 2016 Jan;62(1):227-35. doi: 10.1373/clinchem.2015.244251. Epub 2015 Oct 1. Clin Chem. 2016. PMID: 26430077

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters